Acceleration of the Meckel Syndrome by Near-Infrared Light Therapy by Lim, Jinhwan et al.
224
    © 2011 S. Karger AG, Basel
 Original  Paper 
  Nephron Extra 2011;1:224–234 
  Acceleration of the Meckel Syndrome 
by Near-Infrared Light Therapy 
 Jinhwan  Lim    a      Vincent H. Gattone, II     c      Rachel Sinders     c      
Caroline A. Miller     c      Yun Liang     d      Peter Harris     e      
John B. Watkins, III     b      Diane S. Henshel     a  
  a     Department of Public and Environmental Affairs, and   b     Medical Sciences Program, 
Indiana University School of Medicine, Indiana University,   Bloomington, Ind.  , Departments 
of   c     Anatomy and Cell Biology, and   d     Radiology, Indiana University School of Medicine, 
  Indianapolis, Ind.  , and   e     Department of Nephrology, Mayo Clinic,   Rochester, Minn.  , USA
 
 Key  Words 
 Hydrocephalus      Meckel syndrome      Near-infrared light      Renal cysts 
 Abstract 
  Background/Aims:   Phototherapy using a narrow-band, near-infrared (NIR) light (using a light-
emitting diode, LED) is being used to treat certain medical conditions. This narrow-band red 
light has been shown to stimulate cytochrome c oxidase (CCO) in mitochondria that would 
stimulate ATP production and has the ability to stimulate wound healing. LED treatment also 
decreases chemical-induced oxidative stress in tested systems. As renal cystic diseases are 
known to have evidence of oxidative stress with reduced antioxidant protection, we hypo-
thesized that NIR light therapy might ameliorate the renal pathology in renal cystic disease. 
  Methods:   Wistar-Wpk/Wpk rats with Meckel syndrome (MKS) were treated with light therapy 
on days 10–18 at which time disease severity was evaluated. Wpk rats were either treated daily 
for 80 s with narrow-band red light (640–690 nm wavelength) or sham treated. At termination, 
renal and cerebral pathology was evaluated, and renal expression and activity of enzymes were 
assessed to evaluate oxidative stress. Blood was collected for blood urea nitrogen (BUN) deter-
mination, the left kidney frozen for biochemical evaluation, and the right kidney and head fixed 
for morphological evaluation.   Results:   There were no significant effects of LED treatment on 
body weight (BW) or total kidney weight in non-cystic rats. Total kidney weight was increased 
and anephric BW was decreased in cystic versus non-cystic controls. LED reduced BW and total 
kidney weight in cystic rats compared to non-light-treated cystic (control) rats. BUN was already 
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increased almost 6-fold in cystic rats compared to control rats. BUN was further increased al-
most 2-fold with NIR treatment in both non-cystic and cystic rats compared to cystic and con-
trol rats. The hydrocephalus associated with Wpk/Wpk (ventricular volume expressed as total 
volume and as percent of anephric BW) was also more severe in NIR-treated cystic rats com-
pared to the normal control rats. Renal glutathione peroxidase and catalase (CAT) were reduced 
in the cystic kidney while superoxide dismutase and CCO were increased. NIR increased CAT and 
CCO, marginally decreased glutathione S-transferase and slightly decreased glutathione reduc-
tase in cystic rats compared to the normal control rats. The detrimental effects of NIR may be 
related to reduced renal blood flow associated with progression of cystic pathology. Compres-
sion by cysts may not allow sufficient oxygen or nutrient supply necessary to support the in-
creased oxidative phosphorylation-associated cellular activity, and the increased demand in-
duced by NIR-increased CCO may have created further oxidative stress.   Conclusion:   LED 
phototherapy initiated after the onset of symptoms was detrimental to MKS-induced pathol-
ogy. NIR stimulates CCO thereby increasing the kidney’s need for oxygen. We hypothesize that 
cystic compression of the vasculature impairs oxygen availability and the enhanced CCO activ-
ity produces more radicals, which are not sufficiently detoxified by the increased CAT activity. 
  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
  Phototherapy has been used in various forms by humans for millennia. Scientists in the 
Soviet Union and Eastern Europe have been elucidating and characterizing the benefits and 
mechanisms underlying low-power laser (coherent light) therapy and the effects of non-co-
herent light using relatively narrow-band light-emitting diode (LED) arrays  [1] . More recent-
ly, near-infrared (NIR) and narrow-band red light therapy has been employed by NASA, the 
US military, and oncologists to promote plant growth on the space station, and to promote 
wound healing in limited oxygen environments (the space station and submarines), on the 
battlefield, and in pediatric cancer patients   [2]  . The red light wavelength/energy also acti-
vates cytochrome c oxidase (CCO) in mitochondria, thus increasing cellular energy (ATP) 
production   [3]  . This mechanism of enhanced ATP generation is believed to be at least one of 
the mechanisms underlying the beneficial effects of red light therapy for damaged tissues. 
NIR light activation of CCO appears to counteract both methanol-induced and cyanide-
induced toxicity in sensitive nerve cells   [2]  . Initial data from biochemical and cDNA array 
studies indicate that NIR light therapy affects the reduction/oxidation state of cells, changes 
production of oxygen and nitrogen radicals, alters cell cycle and increases the production of 
proteins that control cell-cell and cell-extracellular matrix interactions   [2, 4]  . NIR therapy 
appears to counteract damage induced by the production of oxygen radicals, a leading mech-
anism involved in tissue injury.
    Oxidative stress affects and enhances polycystic kidney disease (PKD) progression, in-
creasing renal damage. Oxidative injury also contributes to the progression of other renal 
conditions   [5]  . Reducing the native antioxidant enzyme protection by depleting glutathione, 
the oxidative radical scavenger and co-factor, increased the severity of PKD in a rat model 
  [6]  . Quantification of oxidative stress markers (heme oxygenase-1) and the antioxidant en-
zymes [glutathione peroxidase (GPx), glutathione S-transferase (GST), and superoxide dis-
mutase (SOD)] in two genetic models of PKD (the Han:SPRD Cy/+ rat and C57BL/6J-cpk/
cpk mouse) provides strong evidence that oxidative stress increases with antioxidant protec-
tion decreasing as the cystic disease progressed  [7] . Reactive oxygen species (ROS) are gener-
ated during metabolism, especially in high ATP-demanding cells such as renal tubule cells. 
Oxidative stress damage is triggered by an imbalance between the production of ROS and 226
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the activity of the antioxidant enzymes [glutathione reductase (GRx), catalase (CAT), SOD, 
and GPx] and scavenger molecules. Suppression of antioxidant enzyme activity would con-
tribute to renal oxidative stress   [8]  .
    There are probably over 20 gene loci that can cause renal cystic phenotypes that include 
(but are not limited to): PKD, nephronophthisis, Bardet-Biedl, Meckel syndrome (MKS) and 
oral-facial-digital syndrome  [9] . However, despite different genes responsible for renal cystic 
conditions, the pathologies share numerous characteristics (i.e. urine concentration defect 
and increased cell proliferation, apoptosis and oxidative stress). MKS is transmitted as an 
autosomal recessive trait and is one of the more severe multiorgan conditions with cystic 
kidneys   [10]  . The Wpk rat model is orthologous to human MKS type 3 caused by the MKS3 
gene   [11]  . In the present study, litters derived from Wpk/+ breeders were subjected to daily 
NIR light treatments after the initiation of pathology and subsequently evaluated. NIR ther-
apy was not efficacious, but deleterious to both the kidney and the cerebral pathologies in 
Wpk/Wpk affected rats.
  M e t h o d s  
  All animal studies were approved by the Indiana University School of Medicine Institu-
tional Animal Care and Use Committee. Wistar Wpk/+ breeders were crossed and resultant 
litters used in the study. Both male and female Wpk/Wpk affected rats as well as intralitter 
normals were either treated with the LED therapy or handled similarly but not exposed to 
any specific light other than the normal room light. Rats were treated once per day with 670 
nm LED (4 J/cm  2 ) for 8 days on postnatal days 10–18. LED arrays of 670 nm wavelength (LED 
bandwidth was   8  25–30 nm at 100% power) were used (Quantum Devices, Inc., Barneveld, 
Wisc., USA). Rats were placed in an uncovered plexiglass box (12.7   !   9   !   7.6 cm) for treat-
ment. The LED array was positioned directly over the animal’s lower back, however because 
of the rats’ size, the light irradiated almost their entire body at the younger ages. Treatment 
with 670 nm light lasted for 80 s, once each day, resulting in a power intensity of 50 mW/cm  2  
and an energy density of 4 J/cm  2  at the skin surface. No heat was generated by the LED array 
and animals were not anesthetized for treatment. Treated rats displayed no evidence of any 
distress from the treatment process.
  At 18 days of age, the rats were weighed, anesthetized, and blood collected for blood urea 
nitrogen (BUN) determination. There is no significant difference at this age between the 
kidneys of male and female suckling rats so they were considered together in each group. The 
left kidney was weighed and then immediately frozen in liquid nitrogen for biochemical 
analysis while the right kidney was fixed in 10% neutral buffered formalin and processed for 
histological evaluation. A slice of kidney was further fixed in 2% glutaraldehyde, 2% para-
formaldehyde in phosphate buffer for electron microscopy. Cyst volume density was deter-
mined from mid transverse histological sections of cystic kidneys using point count stereol-
ogy, which has been described previously   [12]  . For electron microscopy, the tissue was osmi-
cated and processed using standard procedures in the Indiana University School of Medicine 
Electron Microscopy Center (http://anatomy.iupui.edu/core-facilities/electron-microscopy-
center/). Digital photographs were taken and evaluated.
    For antioxidant enzymatic assays, 300 mg of each kidney were homogenized in 4.7 ml 
of 0.1   M   sodium phosophate/5 m  M   EDTA buffer (pH 7.6) using a Polytron homogenizer 
(Glen Mills Inc., Clifton, N.J., USA). The homogenates were centrifuged (1,500   g  , 10 min), 
and the supernatant was re-centrifuged (100,000  g , 1 h) in a Beckman L7-55 centrifuge (Beck-
man Coulter Inc., Fullerton, Calif., USA). The second supernatant fraction (equivalent to 5% 
cytosol) was used to determine protein concentrations and enzyme activities. For the CCO 227
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assay, 300 mg of tissue were homogenized in 1.2 ml of ice-cold 1.15% KCl, and centrifuged 
at 1,500   g   for 10 min at 4    °    C. The supernatant was re-centrifuged at 100,000   g   for 1 h. The 
remaining pellet was resuspended with enzyme dilution buffer (10 m  M   Tris-HCl/250 m  M  
sucrose, pH 7.0) and stored at –80    °   C until used. Total protein was determined spectrophoto-
metrically using a bovine serum albumin standard. Antioxidant enzyme activity was ex-
pressed as units per milligram protein and measured using a Beckman Coulter DU640 spec-
trophotometer. GPx activity was determined by the method of Tappel  [13] . One GPx activity 
unit was defined as the amount of enzyme that transforms 1     mol of NADPH to NADP in 
1 min at 37    °    C. GRx activity was determined by the NADPH-dependent reduction of oxi-
dized glutathione (GSSG) to reduced glutathione (GSH)   [14]  . The oxidation of 1 nmol 
NADPH/min is defined as 1 unit of GRx activity. Cytosolic SOD activity was measured us-
ing xanthine and xanthine oxidase as a superoxide generator and cytochrome c as an indica-
tor in the absence of SOD  [15] . Fifty percent inhibition (IC  50 ) of cytochrome c in the presence 
of superoxide anion was defined as 1 unit of SOD activity. CAT activity was determined by 
measuring the absorption of hydrogen peroxide in the presence of CAT at 240 nm. One unit 
of CAT activity was defined as the amount of enzyme which liberated half the peroxide ox-
ygen from hydrogen peroxide solution (    0.03%) in 100 s at 25    °    C. GST activity was deter-
mined by the GST-catalyzed reaction between GSH and CDNB (1-chloro-2,4-dinitroben-
zene), which produced a dinitrophenyl thioether   [16]  . One unit of GST activity was defined 
as the amount of enzyme producing 1 mmol of CDNB-GSH conjugate/min. CCO activity 
was analyzed using the Sigma CCO assay kit (Sigma, St. Louis, Mo., USA). One unit of CCO 
activity was defined to oxidize 1.0     mol of ferrocytochrome c per minute at pH 7.0 at 25    °   C.
    CT images after contrast enhancement of 2- and 3-week-old male Wistar-Wpk/Wpk 
kidneys were acquired using a Philips Brilliance 64-slice system at 64   !   0.65 mm collima-
tion, 120 kVp and 150 mAs. Iodinated contrast agent (ISOVUE-300; Bracco Diagnostics Inc., 
Princeton, N.J., USA) was infused intravenously through the tail vein followed immediately 
by CT imaging while rats were anesthetized with isoflurane. 
  Statistical analyses were performed using the SAS system 9.13 (SAS Institute, Cary, N.C., 
USA). Data are expressed as means   8   SEM. Mean differences were obtained using one-way 
ANOVA (PROC GLM with Tukey’s post hoc multiple comparisons). Between-group statisti-
cal significance was determined using Dunnett’s t test based on least-square means within 
PROC GLM. A value of p  ^   0.05 was considered statistically significant, and 0.05   ^   p   !   0.1 
was considered marginally significant.
  R e s u l t s  
 NIR treatment had a minimal effect in NIR-treated normal controls (LED control) com-
pared to the non-light-treated normal control rats (control), yet there were dramatic differ-
ences between non-light-treated cystic controls (cystic) and NIR-treated cystic rats 
(cystic+LED). Control cystic rats had the same total body weight (BW) as their littermate 
control normal rats, but had 900% larger kidney weights. NIR treatment caused growth re-
tardation in the cystic rats, and this growth retardation was associated with a smaller cystic 
kidney. But when the kidney weight was expressed as a percent of total BW, no NIR treatment 
effect was evident (  table 1  ). Similarly, absolute cyst volume was increased in the cystic kid-
neys compared to cystic+LED kidneys, however, cyst volume density and cyst volume as a 
percent of total BW were not significantly different (  table 1  ). Similarly, there was no grossly 
obvious difference in the pathology between the cystic and cystic+LED kidneys (  fig. 1  ,   2  ). 
These data suggest that the light treatment caused generalized growth retardation in cystic, 
but not in normal rats (in both body and kidney growth).228
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  BUN was increased 573% in control cystic rats compared to normal control rats, but light 
treatment caused an additional twofold increase in BUN concentrations in both cystic+LED 
and LED-control rat pups compared to the equivalent controls (cystic increase: 188%; non-
cystic increase: 177%), suggesting that there was a detrimental influence of NIR treatment 
that even affected normal rats. Interestingly, NIR treatment also caused an increase in hy-
drocephalus in Wpk/Wpk rats [volume expressed both as absolute volume (in ml, 148%) and 
as a percent of anephric BW (217%);   table 1  ]. While the light was centered on the rear half of 
the rats, it still illuminated almost the entire body as the rats were able to move around a bit, 
Table 1. Characteristics of the study groups
Characteristics Control  LED  treatment
cystic (n = 9) normal (n = 10) cystic (n   = 12) normal (n = 14)
BW, g 38.580.9 38.280.9 29.181.6* 39.880.6
Kidney weight, g 4.6580.30 0.5280.02 3.5680.21* 0.5380.01
% of total BW 12.0380.63 1.3680.03 12.3080.42 1.3380.02
Cyst volume density, % 58.981.4 57.581.9
Cyst volume
ml 2.7280.23 2.0580.14*
% of total BW 7.0980.47 7.1180.42
Fibrosis
Cortex 3.0680.06 1.1080.10 3.2580.10 1.0080.01
Medulla 3.9480.11 1.9080.19 4.0080.12 2.0080.01
Hydrocephalus volume, ml 0.6980.07 1.0280.13*
% of anephric BW 2.0480.19 4.4280.72*
BUN, mg/dl 7587.1 13.181.3 141822 23.281.4*
*   p < 0.05 with LED treatment. 
  Fig. 1.   Light micrographs of LED-treated and control cystic kidneys. Both exhibit an almost indistin-
guishable degree of cystic pathology. Bar = 1 mm. 229
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especially at the earlier ages, which may have contributed to the increased severity of hydo-
cephalus. 
    Glutathione is a major antioxidant pathway in kidney tubules. The GPx activity in the 
kidney (  fig. 3  ) of both cystic and cystic+LED rats showed a significant decrease (p   !   0.0001) 
compared with both normal groups. In the cystic+LED rats, GPx activity was maintained at 
levels similar to those found in the cystic rats. These results indicate that the cystic rats have 
suppressed GPx activity and light treatment has no significant effects on GPx activity. How-
ever, activity of renal GRx (  fig. 3  ) was insignificantly decreased (p   !   0.2) in the cystic kidney 
compared to normal controls, and LED treatment decreased renal GRx activity in both nor-
mal groups (46%; p   !   0.05), which was further reduced in cystic rats (47%, p   !   0.2). GST ac-
tivity (  fig. 3  ) did not change between the cystic rats and the control rats, and LED treatment 
slightly (17%) but insignificantly decreased activity in normal and cystic kidneys. 
  Two major antioxidant enzymes are CAT and SOD. CAT activity ( fig. 3 ) in the cystic rats 
was so suppressed that no activity was measureable. Light treatment alone suppressed CAT 
activity in the control rats by 33% (p   !   0.05), and the activity of CAT in cystic+LED rats was 
suppressed by 76% compared to the control rats (p  !   0.005) and by 64% (p   !   0.08) compared 
to the LED-treated control rats. However, given that CAT activity was virtually completely 
  Fig. 2.   Scanning electron micrographs of glomeruli and cystic tubules. The glomerulus from an LED-
treated affected rat (  a ) appears relatively normal and comparable to that of an LED-treated noncystic rat 
( c ). There does not appear to be any significant visceral epithelial pathology present that would explain 
the decreased renal function. Similarly, the cystic tubules from the LED-treated rat (  b ) is similar to that 
from a control cystic rat (  d ). Bar = 10    m. 230
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suppressed in the cystic rats, light treatment actually increased CAT activity in the cystic 
kidney. SOD activity (  fig. 3  ) was significantly increased in cystic compared to control kid-
neys (45% increase; p   !   0.05). LED treatment caused an insignificant decrease in SOD activ-
ity in both non-cystic and cystic kidneys compared to their non-light-treated phenotype 
groups.
    The activity of CCO (  fig. 3  ) was already increased in cystic rats by 91% (p   !   0.004) com-
pared to the control normal rats. LED treatment tended to increase renal CCO activity in 
control kidneys, but significantly increased the renal CCO activity in the cystic kidney (59%; 
p   !   0.0002).
  To potentially explain why the NIR treatment was detrimental, we evaluated renal blood 
flow during disease progression in separate animals. In normal control rats, we performed 
a vascular contrast assessment for the distribution of blood flow within the cystic kidney. At 
2 weeks of age, the cortex exhibited significant contrast, but in a patchy pattern. However, at 
3 weeks, the Wpk/Wpk kidney exhibited minimal evidence of cortical vascular perfusion 
( fig. 4 ). These data suggest that there is a reduction in cortical vascular perfusion with disease 
progression. These data also imply that the renal cortex experienced hypoxia and since the 
remaining, functional tissue must undergo compensatory hypertrophy, the remaining func-
tional tissues would require increased transport activity and increased ATP generation. The 
  Fig. 3.   Changes in the acitivity of antioxidant enzymes and CCO in the kidneys of control, LED control, 
cystic, and cystic+LED rats. Statistical analyses were performed using one-way ANOVA, followed by 
Tukey’s multiple comparison test. Values represent means  8   SEM.   a  p   !   0.05 vs. control group,   b    p   !   0.05 
vs. LED+control group,   c  p   !   0.05 vs. cystic group (n = 10, 14, 9, 10). 231
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increase in CCO in the control cystic kidney probably reflects this compensatory increase in 
remnant tissue. However, further activation of oxidative phosphorylation by LED, in the ab-
sence of sufficient vascular perfusion, may have been deleterious to the remaining function-
al tissues.
  Discussion 
 We hypothesized that low-level light therapy using 670 nm LED would counteract ROS-
induced kidney damage by CCO activation, thereby providing additional energy for the kid-
ney transporters to reduce oxidative stress. It was initially thought that LED might help the 
cystic kidney maintain homeostatic mechanisms in this rodent model of MKS with its rap-
idly progressive form of renal cystic pathology. However, that was not the result of LED treat-
ment.
    Morphological kidney changes are the main diagnostic criteria used to clearly identify 
the existence of and to characterize the type of renal cystic disease   [17]  . By comparison, bio-
chemical and morphological tools are the best approach for determining the mechanisms 
underlying the dysfunctions. The present study combines these two approaches in order to 
characterize and validate both this animal model of genetically aggravated renal cystic dis-
ease, and the use of NIR therapy to reduce the severity and slow disease progression. There 
were no significant histopathological changes indicating either amelioration or further de-
generation of the renal tissues after LED treatment. Biochemically, there was worsening of 
the oxidative stress with reduced antioxidant protection even though CAT, CCO, and oxida-
tive phosphorylation were increased. However, a requirement for this increased generation 
of ATP is to have sufficient blood flow to supply oxygen and nutrients. In this case, as op-
posed to situations where LED treatment has helped, the kidneys had a significantly reduced 
renal blood flow, made more significant by the increased renal mass. The combination of 
increased oxidative phosphorylation with a significantly reduced vascular perfusion appears 
to cause a more severe oxidative stress in the cystic kidney. This increased oxidative stress 
  Fig. 4.   Vascular contrast coronal CT scans of 2- and 3-week cystic 
kidneys. The vascular perfusion of the cortex is noted in the 2-week 
kidney (arrows) as patchy areas with increased contrast material (  a ), 
whereas in the 3-week-old Wpk/Wpk rat (  b  ), there is minimal evi-
dence of cortical contrast material in the kidneys (left kidney is out-
lined), yet some contrast is evident in the inferior vena cava (IVC). 
P = Renal pelvic cavity. 232
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along with a decreased ability of the antioxidant system to compensate appears to have led 
to an accelerated loss of renal function in LED-treated cystic rats.
    ROS are generated during metabolism, especially in high ATP-demanding cells such as 
renal tubule cells. Oxidative stress damage is triggered by an imbalance between the produc-
tion of ROS and the activity of the antioxidant enzymes. Reducing renal antioxidant defense 
capacity could enhance the progression of cyst formation/enlargement, thus increasing renal 
damage, which could then accelerate disease progression   [5]  . Reducing the native antioxi-
dant enzyme protection provided by glutathione actually increased the severity of cystic kid-
ney diseases in a rat model   [6]  . Quantification of the oxidative stress marker (heme oxygen-
ase-1) and antioxidant enzymes (GPx, GST, and SOD) in two genetic models of PKD rats (rat: 
Han:SPRD Cy/Cy; mouse: C57BL/6J-cpk) provided further evidence that antioxidant pro-
tection was decreased in PKD as the disease progressed   [7]  . Renal blood flow is reduced in 
both human   [18, 19]   and rodent models   [20]   with polycystic kidneys. As nephrons are lost 
secondary to the renal cystic pathology, the remaining nephrons undergo a compensatory 
hypertrophy to assume the function from the lost nephrons. Compensatory renal hypertro-
phy is associated with an increase in mitochondrial redox and oxidative stress   [21]  . In the 
rapidly progressive renal cystic disease in the Wpk rat, compensatory hypertrophy in the 
nephrons that are still receiving a good blood supply has already upregulated their mitochon-
drial activity and reduced their antioxidant protection (increased CCO and reduced GPx; 
 fig. 3 ).
    The use of low-level light in the range of far-red to NIR has been evaluated in a number 
of disease states including wound healing of toxic retinal and neuronal injury and ischemic 
heart injury by improving mitochondrial energy metabolism and production   [2]  . LED ther-
apy directly stimulates CCO activity, leading to increased ATP generation   [22, 23]  . Studies 
from our and our collaborator’s laboratories supported LED therapy in retinoprotection 
from toxic injury in rats   [4]   and attenuation of TCDD (2,3,7,8-tetrachloro-dibenzo-  p -diox-
in)- and diabetes-induced oxidative stress in chicken and rat kidneys   [24, 25]  . However, in 
these situations, the tissues under stress still received sufficient vascular perfusion to supply 
the necessary nutrients.
    In this study, we found that the Wpk/Wpk phenotype increased CCO and that in-
creased activity may have already created more oxidative stress, which was further stimu-
lated by LED treatment. This LED-induced activity overwhelmed the antioxidant defensive 
enzyme capacity, evinced by significantly decreased GPx and CAT activity, and significant-
ly increasing SOD activity compared to the normal controls. Since both GPx and CAT are 
responsible for removal of hydrogen peroxide, it is assumed that the increased hydrogen 
peroxide-related oxidative stress damage contributed to the progression of the functional 
demise. That SOD is significantly increased in the control cystic rat kidney compared to the 
control normal rat kidney implies that superoxide was already increased in the diseased 
kidney.
    There is good evidence that cystic kidneys are normally under an increased oxidative 
stress. When rats with a form of autosomal dominant PKD are treated with  L -buthionine(S,R)-
sulfoximine to reduce the antioxidant protection of glutathione, the cystic disease is made 
worse   [6]  . In the cpk mouse, oxidative stress was evidenced by GPx suppression, and this 
stress increases with progressive development of cystic pathology   [7]  . While LED treatment 
reversed the GPx activity suppression seen in the Wistar rat of streptozotocin-induced dia-
betes   [25]  , treatment did not counteract the effects of renal cystic disease on GPx reduction. 
Since there is a reduction in renal blood flow in rodent models of cystic disease   [20]   as well 
as in human autosomal dominant PKD   [18, 19]  , even before there is evidence of renal dys-
function, the failure to correct or ameliorate this GPx reduction may be related to the re-
duced renal vascular perfusion already present.233
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